{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:38:34Z","timestamp":1765888714849,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ensci.2021.100369","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:57:25Z","timestamp":1632358645000},"page":"100369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Circulatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patients"],"prefix":"10.1016","volume":"25","author":[{"given":"Hiromu","family":"Ogura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izzettin","family":"Hatip-Al-Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Suenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda Bolukbasi","family":"Hatip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2021.100369_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ensci.2021.100369_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JPD-150615","article-title":"Systematic review of the relationship between vitamin D and Parkinson\u2019s disease","volume":"6","author":"Rimmelzwaan","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ensci.2021.100369_bb0015","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1073\/pnas.95.7.4013","article-title":"Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons","volume":"95","author":"Saucedo-Cardenas","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ensci.2021.100369_bb0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/08923970802278557","article-title":"Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson\u2019s-like disease","volume":"30","author":"Panaro","year":"2008","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ensci.2021.100369_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in alpha-Synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Alecu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ensci.2021.100369_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-4-49","article-title":"Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson\u2019s disease","volume":"4","author":"Falk","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ensci.2021.100369_bb0035","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s12035-018-1256-9","article-title":"Tyrosine hydroxylase inhibition in Substantia Nigra decreases movement frequency","volume":"56","author":"Salvatore","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ensci.2021.100369_bb0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.23586","article-title":"Angiogenin variation and Parkinson disease","volume":"71","author":"Rayaprolu","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ensci.2021.100369_bb0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2018.00477","article-title":"Genomic effects of the vitamin D receptor: potentially the link between vitamin D, immune cells, and multiple sclerosis","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ensci.2021.100369_bb0050","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/nu10111656","article-title":"Vitamin D: nutrient, hormone, and Immunomodulator","volume":"10","author":"Sassi","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ensci.2021.100369_bb0055","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/mds.27894","article-title":"Multiple system atrophy: recent developments and future perspectives","volume":"34","author":"Meissner","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"7","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2021.100369_bb0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0070","article-title":"Plasma Homocysteine, vitamin B12 and Folate levels in multiple system atrophy: A case-control study","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ensci.2021.100369_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","article-title":"Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy","volume":"89","author":"Koga","year":"2018","journal-title":"J. Neurol. Neurosur. Ps"},{"key":"10.1016\/j.ensci.2021.100369_bb0080","doi-asserted-by":"crossref","first-page":"e00936.1","DOI":"10.1002\/brb3.936","article-title":"Serum vitamin D in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"8","author":"Ouma","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.ensci.2021.100369_bb0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","article-title":"Parkinson\u2019s disease severity levels and MDS-unified Parkinson\u2019s disease rating scale","volume":"21","author":"Martinez-Martin","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tiv.2017.06.008","article-title":"Neurodegenerative signaling factors and mechanisms in Parkinson\u2019s pathology","volume":"43","author":"Goswami","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ensci.2021.100369_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/mp.54.6.419","article-title":"Multiple system atrophy: cellular and molecular pathology","volume":"54","author":"Burn","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.ensci.2021.100369_bb0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mds.25880","article-title":"Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study Littlejohns group","volume":"29","author":"Stankovic","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-131970","article-title":"Why vitamin D in Alzheimer\u2019s disease? The hypothesis","volume":"40","author":"Gezen-AK","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ensci.2021.100369_bb0130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2021.100369_bb0135","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1631\/jzus.B1400005","article-title":"Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson\u2019s disease","volume":"15","author":"Zhu","year":"2014","journal-title":"J. Zhejiang Univ. (Sci.)"},{"key":"10.1016\/j.ensci.2021.100369_bb0140","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1172\/JCI111568","article-title":"Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man","volume":"74","author":"Bell","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ensci.2021.100369_bb0145","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/MNM.0b013e32835674c4","article-title":"Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia","volume":"33","author":"Farid","year":"2012","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ensci.2021.100369_bb0150","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase","volume":"86","author":"Zehnder","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ensci.2021.100369_bb0155","first-page":"1961","article-title":"Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1","volume":"11","author":"Fu","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ensci.2021.100369_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","article-title":"Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain","volume":"29","author":"Eyles","year":"2005","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ensci.2021.100369_bb0165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jnr.490380212","article-title":"Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro","volume":"38","author":"Neveu","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ensci.2021.100369_bb0170","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.ki.5000394","article-title":"25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells","volume":"70","author":"Ritter","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ensci.2021.100369_bb0175","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3182a95818","article-title":"Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard biomarker study","volume":"81","author":"Ding","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2021.100369_bb0180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JPD-130206","article-title":"Memory, mood, and vitamin D in persons with Parkinson\u2019s disease","volume":"3","author":"Peterson","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ensci.2021.100369_bb0185","first-page":"141","article-title":"Bone mineral density and vitamin D status with idiopathic Parkinson\u2019sDisease","volume":"21","author":"Topal","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ensci.2021.100369_bb0190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JPD-171122","article-title":"The role of vitamin D in disease progression in early Parkinson\u2019s disease","volume":"7","author":"Sleeman","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ensci.2021.100369_bb0195","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.49.5.1273","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in Parkinson\u2019s disease","volume":"49","author":"Sato","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2021.100369_bb0200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7","article-title":"Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenyl- pyridine","volume":"62","author":"Shinpo","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ensci.2021.100369_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/mds.24016","article-title":"25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson\u2019s disease","volume":"27","author":"Suzuki","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2021.100369_bb0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12974-018-1266-6","article-title":"Viana, vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats","volume":"15","author":"Lima","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ensci.2021.100369_bb0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","article-title":"Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson\u2019s disease, shifting M1 to M2 microglia responses","volume":"12","author":"Calvello","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.ensci.2021.100369_bb0220","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4172\/2161-0460.1000200","article-title":"Low serum 25(OH)D levels in Parkinson\u2019s disease; a non specific marker of Neurodegeneration?","volume":"5","author":"Enrica","year":"2015","journal-title":"J. Alzheim. Dis. Parkinson."},{"key":"10.1016\/j.ensci.2021.100369_bb0225","article-title":"Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis","author":"Cong","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.ensci.2021.100369_bb0230","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","article-title":"Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease","volume":"97","author":"Suzuki","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ensci.2021.100369_bb0235","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson\u2019s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA working group. Italian longitudinal study on aging","volume":"9","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2021.100369_bb0240","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ane.12796","article-title":"Gender differences in Parkinson\u2019s disease: A clinical perspective","volume":"136","author":"Georgiev","year":"2017","journal-title":"Acta Neurol. Scand."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650221000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650221000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:18:46Z","timestamp":1762503526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650221000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"alternative-id":["S2405650221000617"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2021.100369","relation":{},"ISSN":["2405-6502"],"issn-type":[{"type":"print","value":"2405-6502"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patients","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2021.100369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100369"}}